发明名称 BLADDER CANCER TREATMENT INCLUDING DECISION AT TUMOR ENZYME LEVEL
摘要 <P>PROBLEM TO BE SOLVED: To provide a treatment for individually targeted bladder cancer by taking advantage of propylene glycol concentrations and/or NAD(P)H:quinone oxidoreductase-1 (NQO1), Cytochrome P450 Oxidoreductase (P450R) and Glucose transporter 1 (Glut-1) protein expressions in human bladder transitional cell carcinoma. Ž<P>SOLUTION: A method of treating bladder cancers includes a step of deciding a level of at least one enzyme in a tumor, a step of selecting a treatment based on the level of the at least one enzyme, and a step of giving the treatment; the treatment includes administration of a quinone-based intravital reductive medicament alone or in combination with another treatment. Ž<P>COPYRIGHT: (C)2010,JPO&INPIT Ž
申请公布号 JP2010116416(A) 申请公布日期 2010.05.27
申请号 JP20100022599 申请日期 2010.02.03
申请人 SPECTRUM PHARMACEUTICALS INC;UNIV OF BRADFORD 发明人 PHILLIPS ROGER M;LENAZ LUIGI
分类号 A61K45/00;A61K31/404;A61K45/06;A61P35/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址